---
title: "Fabtech Technologies Ltd (FABTECH) — Share Price, Financials & Analysis"
symbol: "FABTECH"
company: "Fabtech Technologies Ltd"
canonical: "https://tapetide.com/stocks/FABTECH"
isin: "INE0HF201011"
nse_symbol: "FABTECH"
bse_code: "544558"
sector: "Healthcare"
industry: "Medical Equipment"
market_cap_cr: 650.36
generated_at: "2026-09-13T18:45:20.593Z"
---

# Fabtech Technologies Ltd (FABTECH)

Canonical page: https://tapetide.com/stocks/FABTECH

## Company

- **NSE Symbol:** FABTECH
- **BSE Code:** 544558
- **ISIN:** INE0HF201011
- **Sector:** Healthcare
- **Industry:** Medical Equipment
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-10-07
- **CEO:** Mr. Ashwani Kumar Singh
- **Employees:** 187
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** fabtechnologies.com

## About

Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.[1]

## Latest Price

- **Price:** ₹147.02
- **Change:** -0.4 (-0.27%)
- **Open:** ₹146
- **Day High:** ₹148.35
- **Day Low:** ₹146
- **Previous Close:** ₹147.42
- **Volume:** 80611
- **As Of:** 2026-09-11T10:01:39+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:56.623889Z.

- **Market Cap:** ₹650.36 Cr
- **Classification:** Microcap
- **P/E (reported):** 13.5
- **P/E (TTM):** 11.05
- **EPS (TTM):** ₹13.31
- **Book Value:** ₹94.43
- **Price to Book:** 1.57
- **Dividend Yield:** 0.41%
- **ROE:** 26.83%
- **ROCE:** 31.09%
- **Debt to Equity:** 0.17
- **Revenue (yearly):** ₹410.77 Cr
- **Net Income:** ₹36.49 Cr
- **EBITDA:** ₹35 Cr
- **52-Week High:** ₹262.8
- **52-Week Low:** ₹132.7
- **RSI (14):** 46.57

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 61.46 | 9% |
| growth | 50 | 9% |
| momentum | 32.18 | 12% |
| ownership | 57.36 | 24% |
| quality | 47.81 | 22% |
| valuation | 78.66 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 35.8% CAGR over last 5 years

### Weaknesses

- Earnings include an other income of Rs.23.3 Cr.
- Company has high debtors of 182 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -159.8% | — | 86.57% |
| ebitda margin growth | -76.95% | -42.27% | -51.5% | -39.87% |
| net income growth | -81% | -21.53% | 19% | 36% |
| revenue growth | -53.56% | 22.29% | 28% | 28% |
| roce | -80.21% | 10.88% | -13.66% | 33.46% |
| roe | -80.92% | 29.99% | 23.97% | 62.9% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 58.74 | 104.32 | 134.86 | 68.01 | 121.48 | 62.76 | 158.52 | 74.98 |
| Expenses | 54.15 | 81.45 | 116.5 | 74.22 | 91.02 | 74.36 | 136.31 | 70.74 |
| Operating Profit | 4.59 | 22.87 | 18.36 | -6.21 | 30.46 | -11.6 | 22.21 | 4.24 |
| OPM % | 7.81 | 21.92 | 13.61 | -9.13 | 25.07 | -18.48 | 14.01 | 5.65 |
| Other Income | 2.36 | 1.75 | 3.29 | 2.75 | 3.18 | 7.1 | 9.85 | 3.15 |
| Interest | 0.24 | 0.43 | 1.09 | 1.34 | 1.07 | 0.87 | 0.88 | 0.86 |
| Depreciation | 0.7 | 0.69 | 0.63 | 1.39 | 1.31 | 1.31 | 1.29 | 1.3 |
| Profit before tax | 6.01 | 23.5 | 19.93 | -6.19 | 31.26 | -6.68 | 29.89 | 5.23 |
| Tax % | 14.81 | 12.98 | 24.23 | -1.13 | 10.08 | -15.12 | 26.23 | 19.69 |
| Net Profit | 5.12 | 20.46 | 15.09 | -6.13 | 28.11 | -5.68 | 22.06 | 4.21 |
| EPS in Rs | 1.58 | 6.32 | 4.66 | -1.89 | 8.68 | -1.28 | 4.96 | 0.95 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 133 | 121 | 257 | 194 | 226 | 327 | 411 | 418 |
| Expenses | 119 | 110 | 225 | 169 | 191 | 288 | 376 | 372 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 35 | 45 |
| OPM % | 11 | 9 | 12 | 13 | 15 | 12 | 9 | 11 |
| Other Income | 5 | 2 | 4 | 10 | 6 | 27 | 23 | 23 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 4 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 | 5 |
| Profit before tax | 16 | 11 | 31 | 28 | 36 | 60 | 48 | 60 |
| Tax % | 27 | 29 | 25 | 22 | 24 | 23 | 21 | — |
| Net Profit | 12 | 8 | 23 | 22 | 27 | 46 | 38 | 49 |
| EPS in Rs | 12390 | 8040 | 84.28 | 78 | 92.44 | 14.34 | 8.63 | 13.31 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 7 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 3 | 3 | 3 | 32 | 44 |
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 |
| Borrowings | 1 | 9 | 21 | 35 | 13 | 84 | 70 |
| Other Liabilities | 84 | 70 | 83 | 89 | 125 | 170 | 164 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Fixed Assets | 2 | 2 | 5 | 4 | 22 | 94 | 78 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 26 |
| Other Assets | 109 | 116 | 150 | 190 | 226 | 318 | 550 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 654 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 64 | -9 | -3 | -14 | 60 | -36 | 0 |
| Cash from Investing Activity | -28 | 4 | -9 | 2 | -30 | -20 | -112 |
| Cash from Financing Activity | -23 | 6 | 8 | 12 | -12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | -4 | 0 | 18 | -20 | 78 |
| Free Cash Flow | 64 | -9 | -4 | -14 | 59 | -61 | 5 |
| CFO/OP | 417 | -65 | 4 | -15 | 196 | -68 | 36 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 110 | 135 | 120 | 187 | 156 | 168 | 182 |
| Inventory Days | 22 | 39 | 17 | 69 | 88 | 119 | 32 |
| Days Payable | 82 | 150 | 136 | 215 | 195 | 198 | 159 |
| Cash Conversion Cycle | 51 | 25 | 1 | 41 | 49 | 89 | 55 |
| Working Capital Days | -19 | 15 | 30 | 65 | 63 | 53 | 90 |
| ROCE % | — | 26 | 48 | 31 | 28 | 22 | 14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2024 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 94.61% | 68.94% | 68.94% | 68.94% | 68.94% |
| FIIs | 0% | 1.91% | 0.03% | 0.08% | 0.02% |
| DIIs | 0% | 11.63% | 1.99% | 2.15% | 2.45% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 16.09% | 22.25% | 21.71% | 21.4% |
| Others | 5.39% | 1.43% | 6.79% | 7.12% | 7.18% |
| No. of Shareholders | 31 | 31 | 31755 | 28620 | 29408 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 6 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 147.89 | Sell |
| EMA (10) | 147.61 | Sell |
| SMA (20) | 147.27 | Sell |
| EMA (20) | 147.84 | Sell |
| SMA (50) | 150.26 | Sell |
| EMA (50) | 149.64 | Sell |
| SMA (100) | 153.49 | Sell |
| EMA (100) | 154.47 | Sell |
| SMA (200) | 165.43 | Sell |
| EMA (200) | 168.89 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.14 | Neutral |
| MACD (12,26,9) | -0.51 | Buy |
| Stochastic (14,3,3) | 37.35 | Neutral |
| ADX (14) | 16.01 | Neutral |
| Williams %R (14) | -68.54 | Neutral |
| ATR (14) | 4.39 | Neutral |
| ROC (12) | 0.02 | Buy |
| Stoch RSI (14) | 17.38 | Buy |
| UO (7,14,28) | 32.58 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b233778f-d41e-4018-8c6f-915a107227d0.pdf) |
| 2026-08-26 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e882eac-46d6-4a58-afc8-b706c40231f8.pdf) |
| 2026-08-24 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef83f150-e2a0-4229-8f54-9715b54b6049.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7496ab8-d6bf-4508-8eee-4e3f2e1ecd8f.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=822b5ccf-a848-4a8d-804b-f12a6d92beca.pdf) |
| 2026-08-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58f4fe9a-de83-4b77-a2b1-9807d23cb387.pdf) |
| 2026-08-01 | [Letter To Members](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdbd2ee4-1e8e-40a3-b9f7-e611253e1461.pdf) |
| 2026-07-31 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e04aec7e-957d-4e45-9c8c-2b79504cc5be.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f07d2ee2-a66b-4edd-baef-073d43b76613.pdf) |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0c0add5-2fae-421d-95cd-3c41329dda7c.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3dea6cc-709c-44dd-af2c-2f60cbb6bcc8.pdf) |
| 2026-04-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d48a3a51-ee31-4def-b45a-40e6b1b26053.pdf) |
| 2026-02-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9603871-ccbe-43de-b23f-370648698ed9.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9b483cb-0d04-4716-910d-044679c19bff.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05387b99-94ad-498e-bd73-541c286386ea.pdf) |
| 2026-06-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd23136b-709d-4356-9fe9-37b3a5e7eab5.pdf) |
| 2026-04-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e29445f-511b-460a-bdd5-8f4ab4ccc0b8.pdf) |
| 2026-02-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e99b4b88-10d1-4cda-9ce4-7565808be8c9.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b8b6588-a5ce-4b17-a50d-07f8c1cd06ce.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97f59731-4b43-438c-85e7-02db80835455.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Financial Results For First Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba8f3e8d-5899-4466-bbe4-4592af5584ff.pdf) |
| 2026-04-27 | [Outcome Of Board Meeting For Audited Financial Results For FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53ec1f35-7c9c-4d5e-ad41-85aaf61b6d75.pdf) |
| 2026-02-02 | [Unaudited Financial Results Of Quarter And Nine-Month Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74087ac0-4a62-4e25-9f8a-e4ef1f99ce55.pdf) |
| 2025-11-04 | [Unaudited Standalone And Consolidated Financials Results Of The Company For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f817dbbb-0739-4129-a0ab-a0051410a1da.pdf) |
| 2025-11-04 | [Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26767725-146a-48af-af3c-7873f066ef99.pdf) |
| 2025-10-27 | [Unaudited Standalone And Consolidated Financials Results Of The Company For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5312b144-b6b8-4d56-a64c-5ea10c4fc042.pdf) |
| 2025-10-27 | [Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8b7089a-b4e0-4ba3-b541-9e4b8085c4c7.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Board meeting on April 27, 2026 to approve FY26 audited results and consider dividend. | [Board Meeting Intimation for Audited Financial Results And Dividend For Period Ended March 31, 2026. 9h - Board meeting on April 27, 2026 to approve FY26 audited results and consider dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dc81114f-2e8f-4fd6-8e54-80d57d989497.pdf) |
| 7 May - CRISIL report for quarter ended March 31, 2026 shows IPO proceeds utilization, no deviations, and working capital delay. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 7 May - CRISIL report for quarter ended March 31, 2026 shows IPO proceeds utilization, no deviations, and working capital delay.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/737adf68-c16d-4749-a9a0-02332986ea69.pdf) |
| 6 Apr - DP) Regulations, 2018 for the quarter ended March 31, 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - DP) Regulations, 2018 for the quarter ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a16fef3-e02d-4ef1-8c74-6e9f24276e16.pdf) |
| 5h - Fabtech reported no deviation in IPO fund use for quarter ended March 31, 2026; Rs. 230.30 crore raised. | [Intimation Of Statement Of Deviation Or Variation In Utilization Of Funds For The Quarter Ended March 31, 2026, Raised Through Initial Public Issue ("IPO") 5h - Fabtech reported no deviation in IPO fund use for quarter ended March 31, 2026; Rs. 230.30 crore raised.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/68a8f3fe-e45a-4d46-bb5d-077bfb781c80.pdf) |
| 5h - Board approved FY26 audited results, recommended ₹0.60 dividend, and authorized Oman step-down subsidiary. | [Corporate Action-Board approves Dividend 5h - Board approved FY26 audited results, recommended ₹0.60 dividend, and authorized Oman step-down subsidiary.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/35302513-d107-4037-9425-16d06737e34a.pdf) |
| 5h - Board approved FY26 audited results, recommended ₹0.60 dividend, and authorized Oman step-down subsidiary. | [Board Meeting Outcome for Outcome Of Board Meeting Scheduled On April 27, 2026 5h - Board approved FY26 audited results, recommended ₹0.60 dividend, and authorized Oman step-down subsidiary.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/69f05dbb-4427-42d2-a3eb-0010cb4fe792.pdf) |
| 5 Mar - Of Investors/ Analysts Meet scheduled to be held on March 12, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 Mar - Of Investors/ Analysts Meet scheduled to be held on March 12, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40500da8-734c-44e4-8856-308994cd58ca.pdf) |
| 5 Mar - Of Investors/ Analysts Meet scheduled to be held on March 10, 2026 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 Mar - Of Investors/ Analysts Meet scheduled to be held on March 10, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a4a4111-2e48-4d7f-ab6d-965de9ff78d6.pdf) |
| 4 Apr - Fabtech reports ₹900 crore+ order book and strategic projects in animal health, Saudi Arabia and Africa. | [Announcement On Order Booking And Business Updates 4 Apr - Fabtech reports ₹900 crore+ order book and strategic projects in animal health, Saudi Arabia and Africa.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30a92a0c-de0b-4802-bdad-288d11afe391.pdf) |
| 28 Apr - Recording of earnings call for Q4 and FY2026 audited results shared on April 28, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 28 Apr - Recording of earnings call for Q4 and FY2026 audited results shared on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2baa0f9c-d54f-4aee-9baf-75273fe27f65.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a9b483cb-0d04-4716-910d-044679c19bff.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b8b6588-a5ce-4b17-a50d-07f8c1cd06ce.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d9603871-ccbe-43de-b23f-370648698ed9.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e04aec7e-957d-4e45-9c8c-2b79504cc5be.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2025-11-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63b42a2c-4e0f-4fa2-b210-46485477a059.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:45:20.593Z.